Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Shares Issued: 2013-2024

Historic Shares Issued for Abeona Therapeutics (ABEO) over the last 11 years, with Dec 2024 value amounting to $15.5 million.

  • Abeona Therapeutics' Shares Issued fell 83.52% to $10.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $26.4 million, marking a year-over-year decrease of 69.53%. This contributed to the annual value of $15.5 million for FY2024, which is 32.66% down from last year.
  • Abeona Therapeutics' Shares Issued amounted to $15.5 million in FY2024, which was down 32.66% from $23.0 million recorded in FY2023.
  • Abeona Therapeutics' Shares Issued's 5-year high stood at $32.6 million during FY2022, with a 5-year trough of $177,000 in FY2020.
  • In the last 3 years, Abeona Therapeutics' Shares Issued had a median value of $23.0 million in 2023 and averaged $23.7 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 98.96% in 2020, then skyrocketed by 4,448.59% in 2021.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Shares Issued stood at $177,000 in 2020, then surged by 4,448.59% to $8.1 million in 2021, then spiked by 304.92% to $32.6 million in 2022, then declined by 29.51% to $23.0 million in 2023, then plummeted by 32.66% to $15.5 million in 2024.